LAVAL, Quebec–(BUSINESS WIRE)–Altasciences Clinical Research announced today that its companies, Algorithme Pharma and Vince & Associates Clinical Research, have been identified as industry leaders by biopharmaceutical companies worldwide.
This is the third consecutive year that Algorithme Pharma has been recognized by the industry for its leadership. This year, Algorithme Pharma excelled in the Expertise and Reliability categories (both “overall” and “small pharma”), earning four distinct CRO Leadership Awards.
For their second consecutive year, Vince & Associates Clinical Research received a total of eight CRO Leadership Awards in all categories: Capabilities, Compatibility, Expertise, Quality and Reliability.
“We are honored to have once again been recognized as a leader in the CRO industry. Our mission has
always been to provide the highest quality early stage clinical development solutions, while exceeding our customers’ expectations with personalized and timely service. These awards recognize and validate the efforts our employees put in on a daily basis to achieve our goals. I am extremely proud of our team,” said Chris Perkin, CEO.
The winners were decided by evaluating 27 different performance metrics, as rated by decision-making executives at biopharmaceutical companies.
“The CROs receiving an award this year are truly at the top of their class, and are deserving of the recognition they receive. Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients.”
Ed Miseta, Executive Editor, Life Science Leader About Altasciences Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences’ full-service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.